Clinic Phase I Study of a New ClassI Antiarrhythmic Drug, Moracizine(En-313).
Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.26.21
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 1995
Authors
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics